China, Japan strengthen cooperation in medical research and development

, a joint venture between China and JapanPharmaceuticalResearch
and Development Co., Ltd., has been established in Shanghai,, and will strengthen cooperation between the two countries in the field of research and development in medicineNew drug research and development cost a large,cycle long, high risk of, because of the people'shealthand life safety, in recent years, the relevant drug regulations are constantly improvingIt is understood that the current world-wide CRO(
contract research organization Contract Research Organization) is to ensure that the quality ofdrugresearch and development to reduce risk
, to provide biopharmaceutical companies with pharmaceutical research and development related professional services of scientific institutions The joint venture of the two sides Rundong Pharmaceutical Research and Development (
Shanghai) Co.
, Ltd is one of the rapid development of China's CRO company
in recent years , the company not only carri
ed out clinical research but also with the relevant departments to carry out a variety of training work of clinical research institution gCP; Guo Yunpei, vice president of the China Pharmaceutical Quality Management Association, who attended the opening ceremony, said that in recent years, China's pharmaceutical market has developed rapidly, but due to fierce competition in the market, resulting in the CRO company fish and dragon mixed, uneven situation , really have strict quality norms of the local CRO company few Rundong Pharmaceutical Research and Development (
Shanghai) Co., Ltd and Japan's CRONOVA Co., Ltd successful cooperation , not only in the market development , quality specifications and resource sharing, etc , can form complementary advantages , but also promote the Sino-Japanese pharmaceutical industry exchanges and development , for high-quality pharmaceutical products to enter the market at an early date, providing technical support